DK1204420T3 - Trehaloseproducerende prokaryotiske celler som vacciner - Google Patents

Trehaloseproducerende prokaryotiske celler som vacciner

Info

Publication number
DK1204420T3
DK1204420T3 DK00954737T DK00954737T DK1204420T3 DK 1204420 T3 DK1204420 T3 DK 1204420T3 DK 00954737 T DK00954737 T DK 00954737T DK 00954737 T DK00954737 T DK 00954737T DK 1204420 T3 DK1204420 T3 DK 1204420T3
Authority
DK
Denmark
Prior art keywords
vaccines
trehalose
prokaryotic cells
producing prokaryotic
producing
Prior art date
Application number
DK00954737T
Other languages
Danish (da)
English (en)
Inventor
Camilo Anthony Leo Selw Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of DK1204420T3 publication Critical patent/DK1204420T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00954737T 1999-08-19 2000-08-18 Trehaloseproducerende prokaryotiske celler som vacciner DK1204420T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919732.9A GB9919732D0 (en) 1999-08-19 1999-08-19 Trehalose producing cells as vaccines
PCT/GB2000/003223 WO2001013942A2 (en) 1999-08-19 2000-08-18 Trehalose producing prokaryotic cells as vaccines

Publications (1)

Publication Number Publication Date
DK1204420T3 true DK1204420T3 (da) 2007-09-17

Family

ID=10859499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954737T DK1204420T3 (da) 1999-08-19 2000-08-18 Trehaloseproducerende prokaryotiske celler som vacciner

Country Status (10)

Country Link
US (1) US20070243200A1 (de)
EP (1) EP1204420B1 (de)
AT (1) ATE359811T1 (de)
AU (1) AU6709500A (de)
DE (1) DE60034460T2 (de)
DK (1) DK1204420T3 (de)
ES (1) ES2286033T3 (de)
GB (1) GB9919732D0 (de)
PT (1) PT1204420E (de)
WO (1) WO2001013942A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8733289B2 (en) * 2008-04-07 2014-05-27 Rich Products Corporation Method for preparing edible aquatic animals for storage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312909A (en) * 1990-03-28 1994-05-17 Gist Brocades, N.V. Recombinant DNA encoding neutral trehalase
US5422254A (en) * 1992-02-14 1995-06-06 Oy Alko Ab Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby

Also Published As

Publication number Publication date
EP1204420B1 (de) 2007-04-18
PT1204420E (pt) 2007-07-20
WO2001013942A2 (en) 2001-03-01
EP1204420A2 (de) 2002-05-15
US20070243200A1 (en) 2007-10-18
GB9919732D0 (en) 1999-10-20
DE60034460T2 (de) 2008-01-03
DE60034460D1 (de) 2007-05-31
WO2001013942A3 (en) 2001-09-20
ATE359811T1 (de) 2007-05-15
ES2286033T3 (es) 2007-12-01
AU6709500A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
EP1594536A4 (de) Adjuvante influenza-vakzine
ATE321569T1 (de) Kombinierte impfstoffzusammensetzungen
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
WO2007067681A3 (en) Immunostimulatory compositions and methods
DE69933200D1 (de) Kombinierte impfstoffzusammensetzungen
BR0010704A (pt) Composições e métodos de anti-náusea
NO20052010D0 (no) Immunogen sammensetning
MXPA01011047A (es) Secuencias genomicas de neisseria y metodos para su uso.
WO2001034801A3 (en) Recombinant gelatin in vaccines
MX339406B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
DK1113816T3 (da) Influenzavirus-vaccinesammensætning
PL1954308T3 (pl) Stabilizatory do liofilizowanych szczepionek
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
DZ2283A1 (fr) Composition de vaccin.
GB2386072A (en) Novel vaccine
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2002096936A3 (en) Daptomycin and related analogs in crystalline form, their preparation and use
FR2798291B1 (fr) Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner